Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ASHLEY NICHOLE COLLINS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1679162366
CMS profile
10710723
Location
TERRE HAUTE, IN

General Payments · PY2021–2024

$1,886.92

  • Reported across 103 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$669.15

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $669.15 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $200.06 11
Novo Nordisk AS $145.40 8
Acerta Pharma LLC $87.34 5
Lilly USA, LLC $73.96 4
GlaxoSmithKline, LLC. $44.86 3
Phathom Pharmaceuticals, Inc. $40.82 2
NOVARTIS PHARMACEUTICALS CORPORATION $28.19 1
DEXCOM, INC. $24.51 1
Exact Sciences Corporation $24.01 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $104.46 6
PY2022 $190.32 10
PY2023 $922.99 51
PY2024 $669.15 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.38 01/05/2024 Food and Beverage Undisputed 01/23/2026 1106938361 CMS
ABBVIE INC. $10.18 02/02/2024 Food and Beverage Undisputed 01/23/2026 1106938363 CMS
ABBVIE INC. $15.61 02/22/2024 Food and Beverage Undisputed 01/23/2026 1106938365 CMS
ABBVIE INC. $19.61 02/29/2024 Food and Beverage Undisputed 01/23/2026 1106938367 CMS
ABBVIE INC. $19.54 04/25/2024 Food and Beverage Undisputed 01/23/2026 1106938369 CMS
ABBVIE INC. $12.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 1106938371 CMS
ABBVIE INC. $26.63 06/27/2024 Food and Beverage Undisputed 01/23/2026 1106938373 CMS
ABBVIE INC. $14.02 07/11/2024 Food and Beverage Undisputed 01/23/2026 1106938375 CMS
ABBVIE INC. $19.79 08/01/2024 Food and Beverage Undisputed 01/23/2026 1106938377 CMS
ABBVIE INC. $5.88 10/10/2024 Food and Beverage Undisputed 01/23/2026 1106938379 CMS
ABBVIE INC. $33.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 1106938381 CMS
AstraZeneca Pharmaceuticals LP $17.48 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105698998 CMS
AstraZeneca Pharmaceuticals LP $16.04 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104769724 CMS
AstraZeneca Pharmaceuticals LP $21.77 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105734321 CMS
AstraZeneca Pharmaceuticals LP $16.59 11/07/2024 Food and Beverage Undisputed 01/23/2026 1105290403 CMS
AstraZeneca Pharmaceuticals LP $15.46 12/06/2024 Food and Beverage Undisputed 01/23/2026 1104666657 CMS
Dexcom, Inc. $24.51 02/09/2024 Food and Beverage Undisputed 01/23/2026 1153350584 CMS
Exact Sciences Corporation $24.01 01/11/2024 Food and Beverage Undisputed 01/23/2026 1114537381 CMS
GlaxoSmithKline, LLC. $13.77 01/13/2024 Food and Beverage Undisputed 01/23/2026 1116707059 CMS
GlaxoSmithKline, LLC. $13.82 01/18/2024 Food and Beverage Undisputed 01/23/2026 1116615314 CMS
GlaxoSmithKline, LLC. $17.27 08/22/2024 Food and Beverage Undisputed 01/23/2026 1116524014 CMS
Lilly USA, LLC $20.09 02/14/2024 Food and Beverage Undisputed 01/23/2026 1135570867 CMS
Lilly USA, LLC $16.55 06/07/2024 Food and Beverage Undisputed 01/23/2026 1135580554 CMS
Lilly USA, LLC $20.82 09/19/2024 Food and Beverage Undisputed 01/23/2026 1135580556 CMS
Lilly USA, LLC $16.50 10/24/2024 Food and Beverage Undisputed 01/23/2026 1135551909 CMS
Novartis Pharmaceuticals Corporation $28.19 04/11/2024 Food and Beverage Undisputed 01/23/2026 1086745547 CMS
Novo Nordisk Inc $14.41 01/05/2024 Food and Beverage Undisputed 01/23/2026 1100369497 CMS
Novo Nordisk Inc $19.04 03/21/2024 Food and Beverage Undisputed 01/23/2026 1100260627 CMS
Novo Nordisk Inc $22.98 05/02/2024 Food and Beverage Undisputed 01/23/2026 1100580858 CMS
Novo Nordisk Inc $12.07 07/18/2024 Food and Beverage Undisputed 01/23/2026 1100523043 CMS
Novo Nordisk Inc $19.11 07/25/2024 Food and Beverage Undisputed 01/23/2026 1100627214 CMS
Novo Nordisk Inc $23.74 10/31/2024 Food and Beverage Undisputed 01/23/2026 1100350000 CMS
Novo Nordisk Inc $23.43 11/14/2024 Food and Beverage Undisputed 01/23/2026 1100647571 CMS
Novo Nordisk Inc $10.62 11/21/2024 Food and Beverage Undisputed 01/23/2026 1100591266 CMS
Phathom Pharmaceuticals, Inc. $26.40 03/09/2024 Food and Beverage Undisputed 01/23/2026 1151156715 CMS
Phathom Pharmaceuticals, Inc. $14.42 10/03/2024 Food and Beverage Undisputed 01/23/2026 1151156717 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.